中财网 中财网股票行情
博瑞医药(688166)财务分析指标    年份：
截止日期2024-03-312023-12-312023-09-302023-06-302023-03-31
营业总收入(万元)34013.31117951.7591487.7858748.2030493.74
营业收入(万元)34013.31117951.7591487.7858748.2030493.74
营业总成本(万元)26734.12100428.0269959.9247482.5522895.27
营业成本(万元)14569.4152141.4037893.9225834.2712539.42
净利润(万元)6178.4817606.6518688.3610538.497076.95
归属于母公司的净利润(万元)6406.9920246.6019179.0710944.047076.95
营业利润(万元)7069.1719024.4419795.6511354.367560.56
利润总额(万元)7058.7018877.0119768.8311327.667560.56
少数股东损益(万元)-226.01-2904.24-1505.00-1105.08-472.49
基本每股收益(元)0.15(元)0.48(元)0.45(元)0.26(元)0.17(元)
稀释每股收益(元)0.15(元)0.48(元)0.45(元)0.26(元)0.17(元)
非经常性损益(万元)-14.451615.34--446.78105.83
扣除非经常性损益后净利润(万元)6421.4418631.2718770.4910497.266971.12
总资产(万元)508750.69503183.14496578.35481406.15477703.40
总负债(万元)261334.18261424.78252504.22246091.14240837.94
归属于母公司股东权益合计(万元)242745.71236861.54237787.75229615.89230533.76
股东权益合计(万元)247416.51241758.35244074.13235315.00236865.46
实收资本(股本)(万元)42246.6642246.6542246.5442246.5442246.51
资本公积(万元)105713.31105713.20105599.02105535.24105098.24
未分配利润(万元)89450.9483043.9582848.2174613.1775562.19
经营活动产生的现金流量净额(万元)14846.1819476.559882.845176.252506.01
经营活动现金流入小计(万元)37572.30107588.4976874.6047680.2827359.69
经营活动现金流出小计(万元)22726.1288111.9466991.7642504.0224853.67
投资活动产生的现金流量净额(万元)-13837.87-43985.36-36758.77-34318.89-23920.32
投资活动现金流入小计(万元)--13390.355219.9744.221349.84
投资活动现金流出小计(万元)13837.8757375.7041978.7434363.1225270.16
筹资活动产生的现金流量净额(万元)-1097.146161.126668.382462.565542.41
筹资活动现金流入小计(万元)26294.6674623.2461927.5839718.7819350.85
筹资活动现金流出小计(万元)27391.8068462.1255259.2037256.2213808.44
期末现金及现金等价物余额(万元)97096.1997104.0894585.0988388.3898926.98
最后修改日期2024-04-272024-04-272023-10-262023-08-272023-04-25
↑返回页顶↑

转至博瑞医药（688166）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。